Mesh exposure · vaginal prolapse
Transvaginal permanent mesh probably leads to higher mesh exposure compared with native tissue repair (moderate certainty).
1 finding from 1 review
Bladder function · vaginal prolapse
Transvaginal permanent mesh probably leads to higher bladder function compared with native tissue repair (moderate certainty).
1 finding from 1 review
De novo dyspareunia (pain during sexual intercourse) review 1 to 3 years · vaginal prolapse
Transvaginal permanent mesh showed no clear difference in painful intercourse ‐ de novo dyspareunia compared with native tissue repair (moderate certainty).
1 finding from 1 review
Quality of life · vaginal prolapse
It is very uncertain whether transvaginal permanent mesh changes quality of life compared with native tissue repair (very low certainty).
1 finding from 1 review
Awareness of prolapse · vaginal prolapse
Transvaginal biological graft showed no clear difference in awareness of prolapse (1 to 3 years) compared with native tissue repair (moderate certainty).
1 finding from 1 review
Regression of endometrial hyperplasia (with or without atypia) to proliferative, secretory, or atrophic endometrium · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin changes regression of endometrial hyperplasia (with or without atypia) to… compared with megestrol (very low certainty).
1 finding from 1 review
Progression of endometrial hyperplasia to endometrial cancer · endometrial hyerplasia
It is very uncertain whether summary of findings table ‐ Metformin + megestrol changes progression of endometrial hyperplasia to endometrial cancer compared with megestrol (very low certainty).
1 finding from 1 review
Hysterectomy rate · endometrial hyerplasia
It is very uncertain whether summary of findings table ‐ Metformin + megestrol changes hysterectomy rate compared with megestrol (very low certainty).
1 finding from 1 review
Abnormal uterine bleeding ‐ not measured · endometrial hyerplasia
The review found no eligible studies for this question.
1 finding from 1 review
HRQOL ‐ not measured · endometrial hyerplasia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects during treatment · endometrial hyerplasia
1 finding from 1 review
Regression of endometrial hyperplasia (with or without atypia) to proliferative, secretory, or atrophic endometrium · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes regression of endometrial hyperplasia (with or without atypia) to… compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Recurrence of endometrial hyperplasia · endometrial hyperplasia
The review found no eligible studies for this question.
1 finding from 1 review
Progression of endometrial hyperplasia to endometrial cancer · endometrial hyperplasia
1 finding from 1 review
Hysterectomy rate · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes hysterectomy rate compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Abnormal uterine bleeding · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes abnormal uterine bleeding compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Recurrence of endometrial hyperplasia · endometrial hyperplasia
1 finding from 1 review
Adverse effects during treatment ‐ all effects · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ all effects compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Adverse events: nausea · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ nausea compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Adverse effects during treatment ‐ heaviness in lower abdomen · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ heaviness in lower abdomen compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review